Corifollitropin alfa

Refrigerated Storage · New Medicines ·

17362111000001104

Refrigerated Storage

Elonva · Merck Sharp & Dohme Limited

Merck Sharp & Dohme Limited
Elonva
100mcg/0.5ml and 150mcg/0.5ml prefilled syringes

In the event of an inadvertent temperature excursion the following data may be used:
The product may be stored at or below 25°C for a period of up to 1 month.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Contact MSD in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details

See above for detailed information
See above for detailed information

Contact MSD in all cases where a deviation from the recommended storage conditions on the SPC has occurred. Refer to the current BNF for company contact details.

2nd June 2016
London Medicines Information Service

New Medicines

Elonva · Hypogonadotropic hypogonadism - in combination with human chorionic gonadotropin

Information

Elonva
Licence extension / variation
Merck Sharp & Dohme (MSD)
Merck & Co (name used in US for MSD)

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
None

Category

Long-acting version of follicle-stimulating hormone (FSH)
Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). Incidence of congenital hypogonadotropic hypogonadism is approximately 1-10 per 100,000 live births [1].
Hypogonadotropic hypogonadism - in combination with human chorionic gonadotropin
Subcutaneous injection